Peng Chen | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Prof. Peng Chen | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Qingdao University | China

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Prof. Peng Chen's journey in medical research began with a strong foundation in clinical medicine and biomedical sciences. She earned her Bachelor of Medicine degree from Taishan Medical College (1999-2004), where she gained essential medical knowledge and clinical training. Her pursuit of advanced expertise led her to Capital University of Medical Sciences (2004-2007), where she obtained a Master of Science degree, focusing on medical research methodologies and specialized clinical studies. To further deepen her understanding and expertise, she pursued a Doctor of Medicine (2009-2012) at Qingdao University, refining her specialization in ophthalmology and regenerative medicine.

Professional Endeavors 🔬

After completing her master's degree, Prof. Chen embarked on her professional career at the Shandong Eye Institute (2007-2016), a renowned institution dedicated to ophthalmology research. During her tenure, she made significant contributions to vision sciences and ocular disease research, strengthening her expertise in eye-related disorders. In 2016, she transitioned to Qingdao University, where she currently serves as a leading researcher and faculty member. Her role at the university allows her to conduct cutting-edge research on ophthalmology and liver regeneration, mentor young medical scientists, and contribute to the advancement of medical science.

Contributions and Research Focus 🔍

Prof. Chen's research has significantly impacted liver regeneration, macrophage efferocytosis, and ophthalmology, particularly in understanding cellular mechanisms and disease pathophysiology. Some of her key contributions include:

  • Liver Regeneration and Macrophage Efferocytosis: Her recent studies have explored the NLRP3 inflammasome's role in constraining liver regeneration by impairing macrophage efferocytosis (Sci Adv., 2025). Additionally, she has investigated the role of Aquaporin-5 in facilitating liver regeneration via the ROS/GSDMD pathway (Cell Signal., 2025) and how extracellular vesicles containing GAS6 protect the liver from ischemia-reperfusion injury (Cell Death Discov., 2024).
  • Ophthalmology and Ocular Disease Research: She has studied the retinoic acid synthesis pathway in AQP5-deficient mice and its implications for dry eye disease (Invest Ophthalmol Vis Sci., 2024). Her research has also examined the regulation of axon guidance by Slit2 and Netrin-1 signaling in lacrimal gland development (Invest Ophthalmol Vis Sci., 2023).

Prof. Chen’s research not only deepens scientific knowledge in these areas but also paves the way for novel therapeutic strategies for liver and eye diseases.

Accolades and Recognition 🏆

Prof. Chen’s contributions to medical science have been widely recognized through prestigious research grants and peer-reviewed publications. She has received:

  • National Natural Science Foundation of China (2020-2023): RMB 550,000 for research on AQP5’s protective role in lens transparency through miRNA-mediated autophagy.
  • Shandong Provincial Natural Science Foundation (2018-2021): RMB 150,000 for the identification and functional study of Fuchs corneal endothelial dystrophy gene.

Her research has been featured in top-tier scientific journals, including Science Advances, Cell Signal, Cell Death Discovery, and Investigative Ophthalmology & Visual Science, reinforcing her status as a leading expert in regenerative medicine and ophthalmology.

Impact and Influence 🌍

Prof. Chen’s work bridges fundamental research and clinical applications, making a profound impact in both ophthalmology and liver disease treatment. Her findings on macrophage efferocytosis and aquaporins have opened new avenues for therapeutic interventions in liver regeneration, while her contributions to ocular disease mechanisms have enhanced the understanding of corneal and lacrimal gland pathophysiology.

Through her mentorship, collaborations, and academic contributions, she continues to shape the next generation of medical researchers and clinicians, strengthening Qingdao University’s reputation as a hub for medical research excellence.

Legacy and Future Contributions 🚀

With an established track record in liver regeneration and ophthalmic research, Prof. Peng Chen’s future contributions are expected to drive medical innovations in regenerative medicine and precision healthcare. Her work on cellular signaling pathways, extracellular vesicles, and aquaporins will likely inspire new therapeutic breakthroughs in both systemic and ocular diseases. As she continues to lead cutting-edge research, mentor young scientists, and contribute to transformative discoveries, Prof. Chen’s legacy will be one of scientific excellence, innovation, and meaningful impact on global healthcare.

Publications


  • 📄NLRP3 inflammasome constrains liver regeneration through impairing MerTK-mediated macrophage efferocytosis

    • Journal: Science Advances
    • Year: 2025
    • Authors: Wei S, Guan G, Luan X, Yu C, Miao L, Yuan X, Chen P*, Di G*

  • 📄Aquaporin-5 facilitates liver regeneration following hepatectomy via ROS/GSDMD pathway

    • Journal: Cell Signaling
    • Year: 2025
    • Authors: Li B, Di G, Ge H, Song P, Han W, Sun H, Wang D, Chen P*, Wang Y*

  • 📄Extracellular vesicles containing GAS6 protect the liver from ischemia-reperfusion injury by enhancing macrophage efferocytosis via MerTK-ERK-COX2 signaling

    • Journal: Cell Death Discovery
    • Year: 2024
    • Authors: Miao L, Yu C, Guan G, Luan X, Jin X, Pan M, Yang Y, Yan J, Chen P*, Di G*

  • 📄Reticulated Retinoic Acid Synthesis is Implicated in the Pathogenesis of Dry Eye in Aqp5 Deficiency Mice

    • Journal: Investigative Ophthalmology & Visual Science
    • Year: 2024
    • Authors: Ge H, Di G, Li B, Han W, Song P, Han S, Wang D*, Chen P*

  • 📄Regulation of Axon Guidance by Slit2 and Netrin-1 Signaling in the Lacrimal Gland of Aqp5 Knockout Mice

    • Journal: Investigative Ophthalmology & Visual Science
    • Year: 2023
    • Authors: Bai Y, Di G, Ge H, Li B, Zhang K, Zhang D, Wang D*, Chen P*

 

Hyun Min Kim | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Prof. Hyun Min Kim | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Duke Kunshan University | China

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Prof. Hyun Min Kim's journey in the scientific realm began with a Bachelor of Science in Life Science from Hanyang University, Seoul, South Korea, in 1997. This foundational phase nurtured his interest in microbiology, leading to a Master of Science in Life Science (Microbiology) from the same institution in 1999. His academic ascent culminated in a Ph.D. in Applied Biology (Genetics and Molecular Cell Biology) at Georgia Institute of Technology, USA, in 2009, where he explored genome instability, tri-nucleotide repeats, and their genetic implications. This solid academic grounding propelled him toward groundbreaking discoveries.

👨‍🔬 Professional Endeavors

Prof. Kim’s illustrious career spans continents and decades, beginning as a Chief Research Scientist at Hanyang University Medical School, focusing on cytokine profiling and toll-like receptor proteins. His time as a Research Assistant and later a Post-doctoral Fellow at Harvard Medical School cemented his expertise in genome editing and DNA damage repair mechanisms.
His roles as Associate Professor at Tianjin University and Duke Kunshan University underscore his contributions to epigenetics and the development of CRISPR-Cas9 systems. Currently, he serves as an Associate Professor of the Practice at Duke University, advancing molecular biology through cutting-edge research on histone demethylases and DNA damage repair.

🔬 Contributions and Research Focus

Prof. Kim's research revolves around epigenetic regulation and genome editing. He has made pivotal contributions to understanding histone demethylases' roles in DNA damage repair and cancer pathways. His work on CRISPR-Cas9 has refined genome editing techniques, particularly in C. elegans, enabling advances in genetic and therapeutic research. His publications, spanning high-impact journals like Biomolecules, Frontiers in Genetics, and Nature Communications, highlight his dedication to elucidating molecular mechanisms influencing genetic stability and cancer development.

🏆 Accolades and Recognition

Prof. Kim's academic excellence has been consistently recognized. From early scholarships at Hanyang University to the prestigious Sarstedt® Graduate Student Award for his Ph.D. accomplishments, his journey is marked by accolades. He received the Faculty Teaching Award at Tianjin University and multiple travel and mentorship awards, showcasing his dual strengths as a researcher and educator. His innovative work has also attracted significant funding, including grants from the National Natural Science Foundation of China and the Kunshan Shuangchuang Grant, totaling millions in support for his transformative projects.

🌟 Impact and Influence

Prof. Kim's efforts have shaped the scientific and academic communities. His leadership roles, such as organizing journal clubs at Harvard Medical School and contributing to editorial boards like Life Journal and Jove Journal, underscore his influence. As a mentor, he has guided budding researchers and students, exemplified by his award for mentoring undergraduates at Georgia Tech. His findings in genome stability, CRISPR-Cas9, and epigenetics continue to inspire advancements in genetic engineering and cancer therapy.

✨ Legacy and Future Contributions

With an eye on the future, Prof. Kim remains committed to unraveling the mysteries of molecular genetics and epigenetics. His work lays a foundation for next-generation cancer therapeutics and genome editing platforms. As a leader in both teaching and research, his legacy will undoubtedly endure, fostering innovation and collaboration in life sciences globally.

 

Publications


📄 Torenia sp. Extracts Contain Multiple Potent Antitumor Compounds with Nematocidal Activity, Triggering an Activated DNA Damage Checkpoint and Defective Meiotic Progression

  • Author: Meng, Q., Borris, R.P., Kim, H.-M.
  • Journal: Pharmaceuticals
  • Year: 2024

📄 Exploring the Impact of Onobrychis cornuta and Veratrum lobelianum Extracts on C. elegans: Implications for MAPK Modulation, Germline Development, and Antitumor Properties

  • Author: Meng, Q., Pathak, N., Ren, X., Borris, R.P., Kim, H.-M.
  • Journal: Nutrients
  • Year: 2024

📖 LSD2 Is an Epigenetic Player in Multiple Types of Cancer and Beyond

  • Author: Kim, H.-M., Liu, Z.
  • Journal: Biomolecules
  • Year: 2024

📖 Experimental Insights into the Interplay between Histone Modifiers and p53 in Regulating Gene Expression

  • Author: Kim, H.-M., Zheng, X., Lee, E.
  • Journal: International Journal of Molecular Sciences,
  • Year:  2023

📖 A Decade of CRISPR-Cas Genome Editing in C. elegans

  • Author: Kim, H.-M., Hong, Y., Chen, J.
  • Journal:  International Journal of Molecular Sciences
  • Year:  2022

 

Shuo Qi | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr. Shuo Qi | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Shandong Sport University | China

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Dr. Shuo Qi embarked on a rigorous academic journey, demonstrating an early passion for sports science and rehabilitation. He earned his Bachelor of Science in Sports Rehabilitation from Shandong Second Medical University in 2017. He then pursued a Master of Education in Human Movement Science at Beijing Sport University under the mentorship of Professors Cao Jianmin and Su Hao, completing his studies in 2020. Driven by a desire to explore cutting-edge advancements in human movement, Dr. Qi obtained his Doctorate in Education specializing in Human Movement Science from Shanghai Sport University in 2023, where he was mentored by Professors Wang Xiaohui and Liu Yu.

Professional Endeavors 🏋️‍♂️

Dr. Qi's professional career is marked by significant contributions to sports science and rehabilitation. His roles ranged from being a research assistant at the China Academy of Sport and Health to serving as a sports nutrition advisor and educator at the Air Force Aviation University of the People's Liberation Army. His work extended to genetic and performance monitoring for national wrestling and judo teams. At Shanghai Sport University, Dr. Qi conducted experimental research in neuro-biomechanical technology, showcasing his ability to translate theoretical knowledge into practical applications.

Contributions and Research Focus 🔬

Dr. Qi’s research spans a wide spectrum of human movement science, focusing on neuro-biomechanical ergogenic technology and brain stimulation for enhanced motor performance. He has been a main or key researcher in prestigious national and international projects, such as:

  • Developing anti-load physical fitness programs for flight trainees.
  • Investigating non-invasive deep brain stimulation to enhance motor abilities in collaboration with institutions like Harvard Medical School.
  • Exploring the role of androgen receptors in muscle physiology through periodic stretching.

His publications, which appear in high-impact journals such as Brain Stimulation, Molecular Neurobiology, and Frontiers in Human Neuroscience, have established him as a thought leader in neuroplasticity and sports performance enhancement.

Accolades and Recognition 🏅

Dr. Qi's scientific rigor and contributions have been recognized through participation in groundbreaking research funded by bodies like the National Natural Science Foundation of China. As a first author, he has published multiple SCI-indexed articles, earning recognition in elite academic circles. His systematic reviews and experimental studies on brain stimulation and gene polymorphisms have set benchmarks in sports science research.

Impact and Influence 🌍

Dr. Qi's work bridges the gap between neuroscience and sports performance, offering transformative insights into enhancing physical and cognitive abilities. His research on non-invasive brain stimulation has practical implications for athletes, medical professionals, and military personnel. By collaborating with global institutions, Dr. Qi has elevated the scientific dialogue on sports biomechanics and neuroplasticity to an international platform.

Legacy and Future Contributions  🚀

As a rising expert in sports science, Dr. Qi’s commitment to advancing neuro-biomechanical technologies places him at the forefront of innovative research. His ongoing projects promise to redefine training methodologies and rehabilitation protocols. With a strong foundation and an expanding network of collaborations, Dr. Qi is poised to make lasting contributions that will shape the future of sports science and human performance enhancement.

 

Publications


📄 Study on the Polymorphic Loci of Explosive Strength-Related Genes in Elite Wrestlers

Author: Shuo Qi, Jinglun Yu, Fanbo Meng, Zhen Wei, Zhiqiang Liang
Journal: Genes
Year: 2024


📄 Noninvasive Deep Brain Stimulation via Temporal Interference Electric Fields Enhanced Motor Performance of Mice and Its Neuroplasticity Mechanisms

Author: Xiaodong Liu, Shuo Qi, Lijuan Hou, Yu Liu, Xiaohui Wang
Journal: Molecular Neurobiology
Year: 2024


📄 Temporally Interfering Electric Fields Brain Stimulation in Primary Motor Cortex of Mice Promotes Motor Skill Through Enhancing Neuroplasticity

Author: Shuo Qi, Xiaodong Liu, Jinglun Yu, Yu Liu, Xiaohui Wang
Journal: Brain Stimulation
Year: 2024


📄 Key Transition Technology of Ski Jumping Based on Inertial Motion Unit, Kinematics, and Dynamics

Author: Jinglun Yu, Xinyu Ma, Shuo Qi, Shanshan Wei, Shuhong Zhang
Journal: BioMedical Engineering Online
Year: 2023


📄 Optimization of Stable Flight Posture of Ski Jumping Based on Computational Fluid Dynamics Simulation Technology

Author: Jinglun Yu, Ziqi Liao, Xinyu Ma, Zhen Wei, Shuhong Zhang
Journal: Sports Biomechanics
Year: 2023


 

Rengui Saxu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr. Rengui Saxu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

China Pharmaceutical University | China                    

Author Profile

Orcid

Early Academic Pursuits 🎓

Dr. Rengui Saxu began his academic journey at Shenyang Medical College, where he pursued a degree in Clinical Medicine Science from 2012 to 2017. During his studies, he completed an internship at Shenyang Central Hospital in 2017, gaining hands-on experience in clinical practice. His academic dedication earned him the National Encouragement Scholarship and the title of Outstanding Graduate, marking his potential as a rising scholar in the field of medicine. Continuing his academic path, Dr. Saxu pursued a Master of Pharmacy Engineering at Tianjin University of Science & Technology from 2017 to 2020. During this time, he took on leadership roles, notably serving as the Head of the Academic Department of the University Graduate Association. His work in pharmacy engineering was recognized with the Zhixing Scholarship for Postgraduate Students.

Professional Endeavors 🏅

Dr. Saxu is currently engaged in advanced research as a Ph.D. candidate in Pharmacology at China Pharmaceutical University (2021-2025). He works under the supervision of Yong Yang, a prominent figure in pharmacological research, and Harvest F. Gu, Chief Scientist at Karolinska Medical School in Sweden. His research spans crucial areas in pharmacology, focusing on drug development and the mechanisms of disease, particularly in relation to diabetes, kidney disease, and cancer.

Contributions and Research Focus 🔬

Dr. Saxu's research contributions are vast, with a focus on pharmacological innovations and therapeutic interventions for diseases like diabetes and cancer. One of his notable patents is a Chinese patent for a method involving selenium-substituted axitinib, which offers anti-tumor applications. His academic publications reflect his deep involvement in cutting-edge research:

  • His studies on asymmetries in adrenal glands and their role in glucocorticoid production provide insights into diabetes-related obesity.
  • He has explored the therapeutic potential of Abelmoschus manihot (L.) in treating diabetic nephropathy via the gut-kidney axis, contributing to the advancement of herbal medicine in disease management.
  • Dr. Saxu has also investigated how Huangkui capsules inhibit aldosterone synthesis in diabetic kidney disease, a promising direction for traditional Chinese medicine.

Accolades and Recognition 🏆

Dr. Saxu's academic excellence has been recognized through numerous prestigious awards:

  • National Encouragement Scholarship
  • Zhixing Scholarship for Postgraduate Students
  • Doctoral Research Incentive Scholarship
  • Outstanding Doctoral Scholarship

These accolades reflect his commitment to research and innovation in the field of pharmacology.

Impact and Influence 🌍

Dr. Saxu's research has had a considerable impact on the medical and pharmacological fields, particularly in the treatment of diabetes and kidney disease. His work on drug therapy and natural compound-based treatments has opened new avenues for understanding and combating complex diseases. His research not only influences medical practices in China but also has international implications, especially in areas related to drug efficacy and safety.

Legacy and Future Contributions 🚀

Dr. Saxu’s future contributions are poised to advance pharmacological research significantly, especially in the areas of cancer therapy and chronic disease management. As a researcher under highly esteemed mentors like Yong Yang and Harvest F. Gu, his ongoing work will likely lead to breakthroughs in targeted therapies and personalized medicine. In the years to come, Dr. Saxu's work will continue to shape the landscape of pharmaceutical sciences, offering hope for more effective and less harmful treatment options. His contributions to medical research, especially in oncology and diabetes, will leave a lasting legacy in global healthcare.

 

Publications


📜 Higher Steroid Production in the Right Adrenal Gland Compared to the Left One in db/db Mice, a Model of Type 2 Diabetic Obesity

  • Authors: Rengui Saxu, Qiming Luo, Yong Yang, Harvest F. Gu
  • Journal: International Journal of Molecular Sciences
  • Year: 2024

📜 Asymmetries of Left and Right Adrenal Glands in Neural Innervation and Glucocorticoids Production

  • Authors: Rengui Saxu, Yong Yang, Harvest F. Gu
  • Journal: International Journal of Molecular Sciences
  • Year: 2023

 

Sakthivel Muthu | Biochemistry, Genetics and Molecular Biology | Best Faculty Award

Dr. Sakthivel Muthu | Biochemistry, Genetics and Molecular Biology | Best Faculty Award

Saveetha Medical College and Hospital | India

Author profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Dr. Sakthivel Muthu’s academic journey began with a Bachelor's degree in Botany from Madurai Kamaraj University in 2005. He continued his education with an M.Sc. in Botany in 2007 and an M.Phil. in Botany from the University of Madras in 2008. His deep interest in plant sciences culminated in a Ph.D. in Botany from the University of Madras in 2016, where his thesis was highly commended.

👨‍🏫 Professional Endeavors

Dr. Muthu's professional career took off as a Post-Doctoral Fellow in Biotechnology at the University of Madras, supported by the prestigious UGC fellowship (2017–2022). He later transitioned into academia as a Guest Faculty member in Biotechnology at the same institution in 2023, bringing his expertise in bioactive compounds and protein biochemistry to students and peers alike.

🔬 Contributions and Research Focus

With a strong passion for interdisciplinary collaboration, Dr. Muthu has delved into various research fields, including protein biochemistry, enzymology, and bioactive compounds from plants and marine algae. His work extends to microbiology and cancer biology, aiming to unlock new therapeutic approaches through natural compounds. His notable contributions include research on phloroglucinol encapsulation for lung cancer and the antibacterial properties of lysozymes.

🏆 Accolades and Recognition

Dr. Muthu's contributions to science have been recognized with multiple awards and fellowships, such as:

  • UGC Post-Doctoral Fellowship (2017–2022)
  • Project Fellowship under the UGC’s BSR Fellowships (2010–2015)

He has also published several high-impact research papers in internationally renowned journals, contributing to fields like nanotechnology, enzymology, and phytochemistry.

🌍 Impact and Influence

Dr. Muthu's research has had a broad influence, particularly in understanding the bioactive properties of natural compounds and their potential in areas like cancer therapy and antibacterial applications. His work with nanoparticles and natural enzyme extraction has provided significant insights into sustainable biotechnological solutions.

🏅 Legacy and Future Contributions

Looking ahead, Dr. Muthu’s dedication to innovative biotechnological research and his willingness to collaborate across disciplines ensure that his contributions to science will continue to inspire future researchers. His ongoing projects, publications, and involvement in patent applications reflect his unwavering commitment to advancing our understanding of biochemistry and biotechnology.

 

Publications


  • 📄 Encapsulation of Phloroglucinol from Rosenvingea intricata Macroalgae with Zinc Oxide Nanoparticles against A549 Lung Cancer Cells
    • Journal: Pharmaceutics
    • Date: 2024-10-05
    • Authors: Sakthivel Muthu, Mythileeswari Lakshmikanthan, Edwin Edward-Sam, Mutheeswaran Subramanian, Lakshmanan Govindan, Afrina Begum Mithen Patcha, Kathiravan Krishnan, Nallusamy Duraisamy, Selvakumari Jeyaperumal, Al Thabiani Aziz

  • 📄 A Comprehensive Review on Anthocyanin-rich Foods: Insights into Extraction, Medicinal Potential, and Sustainable Applications
    • Journal: Journal of Agriculture and Food Research
    • Date: 2024-06
    • Authors: Mythileeswari Lakshmikanthan, Sakthivel Muthu, Kathiravan Krishnan, Ammar B. Altemimi, Noor N. Haider, Lakshmanan Govindan, Jeyaperumal Selvakumari, Zina T. Alkanan, Francesco Cacciola, Yuvaraj Maria Francis

  • 📄 A Bioflocculant Made from Chitosan and Modified Shrimp Waste Might Collect Fresh and Saltwater Microalgae
    • Journal: Biosciences Biotechnology Research Asia
    • Date: 2024-03-30
    • Authors: Nallusamy Duraisamy, Sakthivel Muthu, Kumaran Thangavel, Kathiravan Krishnan, Sivamalar Sathasivam

  • 📄 Extraction, Purification, and Investigation of the Antibacterial Potential of Lysozyme Isolated from the Latex of Calotropis procera
    • Journal: European Food Research and Technology
    • Date: 2024-02-21
    • Authors: Sakthivel Muthu, Venkateshbabu Gopal, Zena Kadhim AL-Younis, Ammar B. Altemimi, Palani Perumal, Mythileeswari Lakshmikanthan, Kathiravan Krishnan, Mazin A. A. Najm, Angelo Maria Giuffrè, Lakshmanan Govindan

  • 📄 Viral Diseases of Ornamental Plants-III
    • Journal: Viral Diseases of Field and Horticultural Crops (Book Chapter)
    • Date: 2023
    • Authors: D. Sundararaj, S. Pushpanathan, S. Muthu, K. Krishnan

 

Ahmed Emam | Biochemistry, Genetics and Molecular Biology | Research for community Impact Award

Dr. Ahmed Emam | Biochemistry, Genetics and Molecular Biology | Research for community Impact Award

Animal Production Research Institute | Egypt

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Dr. Ahmed Emam began his academic journey with a B.Sc. in Agricultural Sciences from Cairo University, majoring in Animal Production. His early interest in animal genetics grew as he pursued an M.Sc. in Poultry Science, investigating the "Effect of leptin on in vitro oocytes maturation in rabbits." His academic achievements culminated in a PhD in Poultry Science, where he focused on comparing genetic biodiversity in Egyptian and European rabbit breeds using genetic markers, a testament to his international collaboration with Porto University in Portugal.

Professional Endeavors 💼

Starting as an Agricultural Engineer in 2005, Dr. Emam climbed the ranks to become a researcher at the Department of Rabbit, Turkey, and Water Fowl Research at the Animal Production Research Institute (APRI). Since 2020, he has been heavily involved in animal genetics research, particularly focusing on rabbit breeds. His dedication is evident through his participation in numerous international projects, including ECOFISH, which explored the organic conversion of fish farms, and collaborations between Egypt and Spain under the Cattleconikta project.

Contributions and Research Focus 🔬

Dr. Emam's research primarily revolves around animal genetics, with a focus on rabbit biodiversity. His work spans various aspects, from microsatellite markers and mitochondrial DNA analysis to the conservation of Egyptian rabbit populations. He has contributed significantly to the field through several key publications, such as his research on the genetic diversity of native Algerian rabbits and the productive efficiency of growing rabbits in Egypt. His role in international conferences, including presenting at the 11th World Rabbit Congress, highlights his influence in the scientific community.

Accolades and Recognition 🏆

Throughout his career, Dr. Emam has received various accolades, including winning the first prize for his scientific poster at the 15th scientific conference of the Egyptian Society of Animal Production. His excellence in research was further recognized when he secured a full grant to attend the prestigious 11th World Rabbit Congress in Qingdao, China. These awards demonstrate his commitment to advancing the field of animal genetics and production.

Impact and Influence 🌍

Dr. Emam's contributions extend beyond academia into the practical realm of animal biodiversity and food security. His studies on the genetic diversity of rabbits have not only enhanced understanding of local breeds but have also impacted food security strategies in Egypt. His work has helped shape policies related to livestock production, ensuring the sustainability of native rabbit breeds amidst changing environmental conditions.

Legacy and Future Contributions 🌟

Dr. Emam’s ongoing projects and upcoming publications promise to further deepen his impact on the field. With his current work focusing on genetic markers for climate-adapted rabbit lines and the status of Egyptian native rabbits along the Nile, he is paving the way for future advancements in animal genetic resources conservation. His legacy will likely be defined by his role in fostering sustainable agricultural practices and enhancing biodiversity within Egypt’s livestock industry.

 

Publications


📄 Mitochondrial DNA (mtDNA) Genetic Variability of Cytochrome B Gene (CYTB) in Three Populations of Native Rabbits in Egypt

  • Authors: Hesham Y.A. Darwish; A.M. Emam
  • Journal: Reproduction and Breeding
  • Year: 2024-09

📄 Egyptian Native Rabbits Along The Nile River: A Microsatellite Marker-Based Genetic Field Study

  • Authors: Ahmed Emam; Reem Mourad; Eslam Faidalah
  • Journal: Journal of Applied Molecular Biology
  • Year: 2024-07-01

📄 Assessment of Genetic Diversity Among Native Algerian Rabbit Populations Using Microsatellite Markers

  • Authors: Abdelbaki Bouhali; Abdelkader Homrani; Nuno Ferrand; Susana Lopes; Ahmed Mostafa Emam
  • Journal: Archives Animal Breeding
  • Year: 2023-07-31

📄 Status and Origin of Egyptian Local Rabbits in Comparison with Spanish Common Rabbits Using Mitochondrial DNA Sequence Analysis

  • Authors: Ahmed Mostafa Emam; Sandra Afonso; Pedro González-Redondo; G.M.K. Mehaisen; A.A.A. Azoz; N.A. Ahmed; N. Fernand
  • Journal: World Rabbit Science
  • Year: 2020-06-30

📄 Rabbits Meat Production in Egypt and Its Impact on Food Security, Small Holders' Income, and Economy

  • Authors: Ahmed M. Emam
  • Journal: Agricultural Research & Technology: Open Access Journal
  • Year: 2020-03-20

 

Fang Wang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr. Fang Wang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Maastricht University | Netherlands

Author Profile

Scopus

Orcid

Early Academic Pursuits 📚

Dr. Fang Wang's academic journey began with a Bachelor’s degree in Pharmacology from Nanchang University, where she developed an oxidative stress model in LO2 cells to test stress amelioration compounds. She continued her studies with a Master's degree in Cell Biology at the same university, focusing on the role of progesterone adiponectin receptor 7 in reproduction and differences in protein post-translational modifications. Currently, she is pursuing a PhD in Cell Biology at Maastricht University, investigating substrate metabolism in diabetic cardiomyopathy and novel treatments using bioactive components from Traditional Chinese Medicine.

Professional Endeavors 🔬

With over seven years of experience, Dr. Wang has built a strong foundation in preclinical research, drug development, scientific communication, and project management. Her professional career includes internships at Shanghai ChemPartner Co., Ltd. and Jiangxi Zhby Biotech Co. Ltd., where she gained hands-on experience in molecular biology testing and research planning. Her current roles involve significant contributions to research in metabolic disorders and male infertility, with a focus on protein translocation and endosome pH regulation.

Contributions and Research Focus 🌟

Dr. Wang’s research primarily targets the intersection of metabolic disorders and drug development, specifically focusing on diabetic cardiomyopathy and the impact of Traditional Chinese Medicine on cardiac health. Her work includes investigating novel treatment strategies and exploring the mechanisms of substrate metabolism, protein translocation, and endosome pH regulation. Her expertise spans a wide range of molecular and cell biology techniques, including advanced imaging and bioinformatics.

Accolades and Recognition 🏆

Dr. Wang has made notable contributions to the field through her publications and presentations at various conferences. Her research on lipid-induced contractile dysfunction and diabetic cardiomyopathy has been recognized in leading journals and upcoming publications. Her work is highly regarded in the scientific community, reflecting her commitment to advancing healthcare solutions.

Impact and Influence 🌍

Dr. Wang's research has a profound impact on understanding and treating metabolic disorders, particularly in diabetic cardiomyopathy. Her innovative approaches and exploration of traditional medicine offer promising solutions for improving patient outcomes and advancing the field of metabolic disease research. Her contributions are shaping new therapeutic strategies and enhancing the quality of life for patients.

Legacy and Future Contributions 🚀

Dr. Wang's future endeavors are set to further explore and develop cutting-edge healthcare solutions. Her ongoing research aims to refine treatment strategies for metabolic disorders and improve the efficacy of drug development. By integrating advanced techniques and traditional medicine, she is poised to make significant strides in the field, contributing to a healthier future and advancing scientific knowledge.

 

Publications 📕


  • 📝 Specific Compounds Derived from Traditional Chinese Medicine Ameliorate Lipid-Induced Contractile Dysfunction in Cardiomyocytes
    • Authors: Fang Wang, Dietbert Neumann, Dimitrios Kapsokalyvas, Martijn Hoes, Francesco Schianchi, Jan Glatz, Miranda Nabben, Joost J. F. P. Luiken
    • Journal: International Journal of Molecular Sciences
    • Year: 2024

  • 📝 Glycolysis-Mediated Activation of v-ATPase by Nicotinamide Mononucleotide Ameliorates Lipid-Induced Cardiomyopathy by Repressing the CD36-TLR4 Axis
    • Authors: Shujin Wang, Han YinYing, Ruimin Liu, Hou M, Dietbert Neumann, Jun Zhang, Wang F, Yumeng Li, Zhao X, Francesco Schianchi et al.
    • Journal: Circulation Research
    • Year: 2024

  • 📝 Progestin and adipoQ receptor 7 (PAQR7) mediate the anti-apoptotic effect of P4 on human granulosa cells and its deficiency reduces ovarian function in female mice
    • Authors: Li J, Liu Y, He J, Wu Z, Wang F, Huang J, Zheng L, Luo T
    • Journal: Journal of Ovarian Research
    • Year: 2024

  • 📝 CD36 as a target for metabolic modulation therapy in cardiac disease
    • Authors: Glatz JFC, Wang F, Miranda Nabben, Luiken JJFP
    • Journal: Expert Opinion on Therapeutic Targets
    • Year: 2021

  • 📝 Diet-induced obesity is associated with altered expression of sperm motility-related genes and testicular post-translational modifications in a mouse model
    • Authors: Wang F, Chen H, Chen Y, Cheng Y, Li J, Zheng L, Zeng X, Luo T
    • Journal: Theriogenology
    • Year: 2020

 

Dong Hee Kim | Biochemistry, Genetics and Molecular Biology | Best Research Award

Dr. Dong Hee Kim | Biochemistry, Genetics and Molecular Biology | Best Research Award

Pusan national university | South Korea

Author Profile

Orcid

🎓 Early Academic Pursuits

Dr. Dong Hee Kim began his academic journey with a Bachelor of Science in Biology from the University of Ulsan, Korea, in 2004. He continued at the same institution for his M.S.-Ph.D. in Biological Sciences under the mentorship of Professor Byung Ju Lee, completing his doctorate in 2012. His thesis, "Studies on the role of NELL2 in neuroprotection and neural differentiation," laid the foundation for his future research endeavors.

💼 Professional Endeavors

Dr. Kim has held various prestigious positions throughout his career. He is currently a Research Fellow at Pusan National University Hospital since November 2022. Previously, he served as a Research Professor at the University of Ulsan from January 2019 to May 2022, and as a Research Fellow at the same university from January 2015 to October 2016. His early postdoctoral work was conducted at UNIST from March 2013 to December 2014.

🧪 Contributions and Research Focus

Dr. Kim's research primarily revolves around neuroprotection, neural differentiation, and the molecular mechanisms underlying neurodegenerative diseases. His notable grants include funding from WISET for studying the function of sodium-glucose cotransporter 2 (SGLT2) inhibitors in the brain, and multiple grants from the NRF of Korea, including studies on TonEBP function in hypothalamic leptin resistance and its role in degenerative brain disorders.

🏅 Accolades and Recognition

Throughout his career, Dr. Kim has received significant recognition for his contributions to biomedical research. His projects have been supported by prestigious grants, highlighting the impact and importance of his work in understanding brain functions and disorders. His research has also resulted in numerous publications in high-impact journals, further establishing his reputation in the field.

🌟 Impact and Influence

Dr. Kim's research has significantly advanced the understanding of neural mechanisms and their implications in neurodegenerative diseases. His work on the transcription regulation of key genes involved in brain function and inflammation has provided new insights into potential therapeutic targets. His publications have been widely cited, indicating the influence of his research on the scientific community.

📚 Legacy and Future Contributions

Dr. Kim's ongoing research continues to push the boundaries of our understanding of the brain. His current projects, funded by substantial grants, promise to uncover new mechanisms of brain function and disease. As he progresses in his career, Dr. Kim is poised to make further groundbreaking discoveries that will contribute to the field of biomedical science and technology.

 

Publications 📘

📄 Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Transcription Regulation of AgRP and POMC Genes

👩‍🔬 Authors: Kim DH*, Lee MJ, Kang D, Khang AR, Bae JH, Kim JY, Kim SH, Kang YH, Yi D.

📕 Journal: Curr Issues Mol Biol.

📅 Year: 2024


📄 Bridging Energy Need and Feeding Behavior: The Impact of eIF2α Phosphorylation in AgRP Neurons

👩‍🔬 Authors: Kim KK, Lee TH, Park BS, Kang D, Kim DH, Jeong B, Kim JW, Yang HR, Kim HR, Jin S, Back SH, Park JW, Kim JG, Lee BJ.

📕 Journal: Diabetes

📅 Year: 2023


📄 Sirtuin 1-Mediated Deacetylation of Hypothalamic TTF-1 Contributes to Energy Deficiency Response

👩‍🔬 Authors: Kang D, Yang HR, Kim DH, Kim KK, Jeong B, Park BS, Park JW, Kim JG, Lee BJ.

📕 Journal: Int J Mol Sci.

📅 Year: 2023


📄 Inhibition of LPAR1 Signaling in PDLSCs Reduces the Inflammatory Paracrine Effect on Primary Astrocyte Cells

👩‍🔬 Authors: Kim DH*, Seo EJ*, Kim YH, Jang IH.

📕 Journal: Int J Oral Biol.

📅 Year: 2022


📄 Transcriptional Regulatory Role of NELL2 in Preproenkphalin Gene Expression

👩‍🔬 Authors: Ha CM*, Kim DH*, Lee TH, Kim HR, Choi JI, Kim Y, Kang DS, Park JW, Oieda S, Jeong JK, Lee BJ.

📕 Journal: Mol Cells

📅 Year: 2022

Yu Yu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr. Yu Yu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Curtin University Medical School | Australia

Author Profile

Scopus

Early Academic Pursuits 🎓

Dr. Yu Yu embarked on her academic journey at the University of Sydney, where she earned her Bachelor of Medical Science in 2005. She further distinguished herself by completing an Honours in Medical Science with First Class in 2006. Her dedication to research culminated in a Doctorate of Philosophy in 2011, marking the beginning of a promising career in medical science and research.

Professional Endeavors 🏢

Currently, Dr. Yu Yu serves as the Program Lead at the Curtin Medical School and the Curtin Health Innovation Research Institute (CHIRI) in Australia. Her professional journey includes significant roles such as Senior Research Fellow at Curtin University since 2017 and Adjunct Senior Lecturer at the University of Western Australia Medical School since 2019. Her past appointments include Research Fellow at Johns Hopkins School of Medicine and Postdoctoral Fellow at the University of Sydney, reflecting a robust background in gynecologic pathology and molecular pharmacology.

Contributions and Research Focus 🔬

Dr. Yu Yu's research contributions are vast and impactful. She has led numerous projects funded by prestigious grants, including the Innovation Seed Fund and the Endometriosis Research Award. Her research primarily focuses on oncology therapeutics, gynecology, and the molecular mechanisms underlying cancer, particularly ovarian cancer. Her notable publications in high-impact journals highlight her expertise in cancer mutations, stem cell biology, and regenerative medicine.

Accolades and Recognition 🏆

Dr. Yu Yu's excellence in research has been recognized through multiple awards and fellowships. She received the Raine Priming Grant, where she was honored as the top-ranked candidate. Additionally, she has been a recipient of the WA Near-Miss Awards for Emerging Leaders and several other grants from the Department of Health Western Australia. Her accolades underscore her significant contributions to medical research and her role as a leader in her field.

Impact and Influence 🌟

Dr. Yu Yu has made a profound impact on the scientific community through her mentoring and teaching roles. She currently supervises multiple PhD and Honours students, fostering the next generation of researchers. Her lectures on cancer mutations and stem cell biology at Curtin University inspire and educate future medical professionals. Moreover, her leadership roles in diversity, inclusion, and belonging initiatives highlight her commitment to creating an inclusive and supportive academic environment.

Legacy and Future Contributions 🔮

Dr. Yu Yu's legacy is defined by her dedication to advancing medical research and her influence as a mentor and educator. Her ongoing research and leadership at Curtin Health Innovation Research Institute ensure that her contributions will continue to shape the field of medical science. Her work in cancer therapeutics and gynecology holds promise for future breakthroughs, and her commitment to diversity and inclusion will leave a lasting impact on the academic community.

 

Publications 📚

📜B cell epitope mapping: The journey to better vaccines and therapeutic antibodies

  • Authors: Asha Joanne De Leon , M. Christian Tjiam , Yu Yu
  • Journal: Biochimica et Biophysica Acta (BBA) - General Subjects
  • Year: 2024

📜Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones

  • Authors: Denisenko, E. , de Kock, L. , Tan, A. , Yu, Y. , Forrest, A.R.R.
  • Journal: Nature Communications
  • Year: 2024

📜Multi-compartment tumor organoids

  • Authors: Lee, M.-H. , Russo, G.C. , Rahmanto, Y.S. , Wang, T.-L. , Wirtz, D.
  • Journal: Materials Today
  • Year: 2022

📜Targeting Tyrosine Kinases in Ovarian Cancer: Small Molecule Inhibitor and Monoclonal Antibody, Where Are We Now?

  • Authors: Rendell, A. , Thomas-Bland, I. , McCuish, L. , Binju, M. , Yu, Y.
  • Journal: Biomedicines
  • Year: 2022

📜MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

  • Authors: Kang, E.Y. , Millstein, J. , Popovic, G. , Kelemen, L.E. , Köbel, M.
  • Journal: Virchows Archiv
  • Year: 2022

 

 

Swayamprabha Sahoo | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Mrs. Swayamprabha Sahoo | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

SOA deemed to be University | India

Author Profile

Scopus

Google Scholar

Early Academic Pursuits

Mrs. Swayamprabha Sahoo began her academic journey with a Bachelor's degree in Biotechnology, graduating with distinction from the College of Basic Science and Humanities at OUAT, Bhubaneswar in 2015. She continued her education with a Master's degree in Biotechnology from the School of Pharmaceutical Science, Bhubaneswar, where she graduated with first-class honors in 2017. Her pursuit of knowledge led her to enroll in a Ph.D. program in Biotechnology at Siksha ‘O’ Anusandhan (Deemed to be University), Bhubaneswar, Odisha, which she has been undertaking since 2018.

Professional Endeavors

Mrs. Sahoo's professional experiences are rooted in her strong educational background and technical skills. She undertook significant research projects during her academic career, including her M.Sc. dissertation on the "Cloning and characterization of DMRT 1 gene in L. rohita" under the guidance of Dr. Jitendra Kumar Sundaray at ICAR-CIFA, Bhubaneswar. She also completed a six-month training at Imgenex India Pvt. Ltd. under the Biotechnology Consortium India Limited (BCIL), focusing on the expression and purification of recombinant Angiotensin converting enzyme (ACE). Additionally, she gained practical experience through a one-month training on NGS at the Institute of Bioinformatics and Applied Biotechnology (IBAB) and attended a workshop on computational biology of drug discovery through molecular docking.

Contributions and Research Focus

Mrs. Sahoo's research contributions are centered on molecular biology and bioinformatics. Her technical expertise includes primer designing, RNA isolation, gene expression analysis, recombinant protein purification, and various molecular biology techniques such as PCR, qPCR, SDS-PAGE, Western blotting, and ELISA. She has also worked extensively on bioinformatics tools like BLAST, Clustal W, and phylogenetic analysis software. Her research projects have focused on areas such as the genomic characterization and distribution of drug-resistant bacteria, which are critical for understanding and combating antibiotic resistance.

Accolades and Recognition

Throughout her academic and professional journey, Mrs. Sahoo has achieved several distinctions. She maintained a first-class academic record and was recognized for her performance in her M.Sc. and B.Sc. programs. Her research work has been published in reputable journals, and she has contributed to significant studies, including the genomic characterization of Klebsiella pneumoniae and the prevalence of multidrug-resistant organisms. Her dedication to research and her contributions to the field of biotechnology have earned her respect and recognition among her peers.

Impact and Influence

Mrs. Sahoo's work has a substantial impact on the field of biotechnology, particularly in the areas of molecular biology and bioinformatics. Her research on drug-resistant bacteria is crucial for developing new strategies to tackle antibiotic resistance, a growing global health concern. Her technical skills and knowledge contribute to advancements in molecular diagnostics and therapeutic development. Her involvement in various training programs and workshops highlights her commitment to continuous learning and skill development, which she imparts to her students and colleagues.

Legacy and Future Contributions

Mrs. Sahoo's legacy in the field of biotechnology is characterized by her dedication to research, education, and professional excellence. As she continues her Ph.D. and engages in further research, she is poised to make significant contributions to understanding and solving complex biological problems. Her future endeavors will likely focus on advancing molecular techniques and bioinformatics tools to improve health outcomes and disease management. Her work serves as an inspiration to aspiring biotechnologists and researchers, encouraging them to pursue excellence and innovation in their fields.

 

Notable Publications

Prevalence of multidrug-resistant Klebsiella pneumoniae in urinary tract infections: A retrospective observational study in eastern India 2024

Identification and Exploration of Transcripts Involved in Antibiotic Resistance Mechanism of Two Critical Superbugs 2024

CRISPR/Cas-Mediated Functional Gene Editing for Improvement in Bioremediation: An Emerging Strategy 2022 (5)

Quantum dots enabled point-of-care diagnostics: A new dimension to the nanodiagnosis 2022 (6)

Does the diverse source of miRNAs affect human health? An approach towards diagnosis and therapeutic management 2022 (2)